ArticleBMC women's health2025
Cervical cancer screening and treatment of VIA positive lesions among women living with HIV in Nairobi and Kajiado counties, Kenya: results from a targeted intervention implemented under the USAID Fahari ya Jamii project in supported HIV clinics.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cervical Cancer Screening with Visual Inspection with Acetic Acid (VIA) among Women Living with HIV in Nairobi, Kenya: Results and Transformation Zone.medRxiv : the preprint server for health sciences · 2026Article
- Integrating pocket colposcope and telecolposcopy into VIA-based screening at primary healthcare centers for cervical cancer prevention in LMICs.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundCervical cancer is the leading cause of cancer-related deaths and the second most common cancer amongst females in Kenya. Women living with HIV (WLHIV) have a six-fold increased risk of developing cervical cancer than women in the general population. As of October 2021, only 23% (34/149) of Fahari ya Jamii (FYJ) project-supported HIV clinics in Nairobi and Kajiado Counties were offering cervical cancer screening for WLHIV. Visual inspection with acetic acid (VIA) positive lesions identified were being treated in only 7% (11/34) of facilities. The project implemented an intervention and sought to determine its outcome on cervical cancer screening and treatment uptake.
methodsThis was a retrospective analysis of data from 1st July 2022 to 30th June 2023. The intervention focused on building the capacity of service providers, determining cervical cancer screening eligibility using Kenya National eligibility screening guidelines, providing screening supplies and commodities, creating service demand through health education by mentor mothers and peer educators, providing screening services and on-site treatment of VIA positive lesions. WLHIV aged 25 to 49 years and receiving care in 64 USAID-FYJ-supported facilities in Nairobi and Kajiado Counties were included in the analyses. Descriptive analyses were performed for sociodemographic characteristics, screening and treatment uptake.
resultsA total of 52% (11,089/21,324) WLHIV received cervical cancer screening services, representing a five-fold increase from pre-intervention figures (2,186). The number of facilities offering screening services increased from 23% (34/149) to 43% (64/149). Of the women screened, 2% (245) VIA positive cervical lesions were identified. Treatment uptake improved from 38% pre-intervention to 90%, with 90% (220/245) of identified cases receiving appropriate treatment. The intervention successfully integrated screening into routine HIV care, facilitated same-day treatment in equipped facilities, and strengthened provider capacity, leading to sustained service delivery improvements.
conclusionsThe intervention increased cervical cancer screening and treatment uptake for VIA positive lesions among WLHIV by integrating services into routine HIV care, enhancing provider training, and ensuring the availability of screening supplies. These findings highlight the potential for scaling up similar strategies in resource-limited settings. Sustained mentorship and continuous monitoring will be essential to further strengthen screening and treatment efforts toward cervical cancer elimination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.